Joel Greenblatt - Gotham Asset Management
Holding/activity history for Protagonist Therapeutics, Inc. (PTGX)
← All PTGX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 21,155 | <0.01 | Reduce 2.04% | <0.01 | $77.00–105.99 · VW $90.88i | $2,229,737 | SEC |
| 2025 Q4 | 21,595 | <0.01 | Reduce 2.72% | <0.01 | $62.24–96.54 · VW $83.04i | $1,886,107 | SEC |
| 2025 Q3 | 22,198 | <0.01 | Reduce 40.47% | <0.01 | $49.38–68.26 · VW $58.83i | $1,474,613 | SEC |
| 2025 Q2 | 37,287 | 0.01 | Add 61.61% | <0.01 | $39.60–57.70 · VW $47.82i | $2,060,591 | SEC |
| 2025 Q1 | 23,072 | <0.01 | Buy | <0.01 | $33.70–60.60 · VW $44.00i | $1,115,762 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $12.80–50.54 · VW $31.63i | SEC | |
| 2021 Q2 | 4,793 | <0.01 | Buy | <0.01 | $24.14–45.93 · VW $36.06i | $215,000 | SEC |
Price snapshot:
Current price$129.89
Avg. buy price$50.99
+/- since buy154.73%
52-week low$50.49
52-week high$141.10